National Institute for Health and Care Excellence guidelines on myocardial revascularisation.

Autor:	Jabbour RJ; Cardiology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.; Faculty of Medicine, University of Southampton, Southampton, UK., Curzen N; Cardiology, University Hospital Southampton NHS Foundation Trust, Southampton, UK nick.curzen@uhs.nhs.uk.; Faculty of Medicine, University of Southampton, Southampton, UK.
Jazyk:	angličtina
Zdroj:	Heart (British Cardiac Society) [Heart] 2023 Jun 26; Vol. 109 (14), pp. 1054-1063. Date of Electronic Publication: 2023 Jun 26.
DOI:	10.1136/heartjnl-2022-321397
Abstrakt:	Cardiologists in the UK predominantly use the National Institute for Health and Care Excellence (NICE) and European Society of Cardiology guidelines to help guide decision-making. This article will appraise the current recommendations from NICE regarding myocardial revascularisation and compare them with other major international guidelines. While there are many similarities, subtle differences exist. These differences arise in part due to the evidence base at time of publication, as well as from the different healthcare systems that they are designed for, and from the cost-effectiveness models that dominate the methodology used by NICE. The clinical implications of the differences between the international guidelines will be analysed. Competing Interests: Competing interests: NC—unrestricted research grants from Boston Scientific, Heartflow and Beckman Coulter; speaker fees/consultancy from Abbot Vascular, Heartflow and Boston Scientific; and travel sponsorship from Edwards, Biosensors, Abbot, Lilly/D-S, St Jude Medical and Medtronic. RJ—none declared. (© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu